935681-01-9

Usage

Uses

Used in Pharmaceutical Industry:
4-BROMO-5-FLUORO-2,3-DIHYDRO-1H-INDEN-1-ONE is used as a building block for the synthesis of pharmaceuticals due to its unique chemical structure and potential biological activities. Its ability to be incorporated into various drug molecules makes it a valuable component in the development of new medications.
Used in Agrochemical Industry:
4-BROMO-5-FLUORO-2,3-DIHYDRO-1H-INDEN-1-ONE is used as a building block for the synthesis of agrochemicals, contributing to the development of new pesticides and other agricultural products. Its unique properties allow it to be a key component in creating effective and innovative agrochemical solutions.
Used in Material Development:
4-BROMO-5-FLUORO-2,3-DIHYDRO-1H-INDEN-1-ONE is used in the development of new materials, leveraging its chemical properties to create innovative and improved materials for various applications.
Used in Chemical Research:
4-BROMO-5-FLUORO-2,3-DIHYDRO-1H-INDEN-1-ONE is used as a valuable compound in chemical research, where its unique structure and potential applications are further explored and studied to advance the field of organic chemistry.

Upstream product

• 700-84-5 5-fluoro-1-indanone 
• 1255209-05-2 3-(2-bromo-3-fluorophenyl)propanoic acid 

Downstream Products

• 1443652-87-6 4-(diphenylmethyleneamino)-5-fluoro-2,3-dihydro-1H-inden-2-ol 

Relevant academic research and scientific papers

NOVEL ANILINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF

[Problem] The present invention provides a novel compound having an S1P1 receptor antagonistic activity. [Solution] The present invention provides a compound represented by the general formula (I): (in the formula, R1, R2

TRPV1 Antagonists

Disclosed herein are compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein X1, L, Rx, Ry, Rz, A, m, n, p, q, s, and positions a and b are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

This invention relates to compounds having structural Formula I: and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure

Prodrugs of compounds that inhibit TRPV1 receptor

Compounds of formula (I) wherein A, R1, R2, and R3 are defined in the specification, and which are useful as therapeutic compounds particularly for treating disorders or conditions associated with inflammation, pain, bladd